By seeing technical data of BioPharmX (NYSE:BPMX) and Sonus Networks (NASDAQ:SONS), some interesting facts appear regarding these companies. One of them in these facts is earning per share growth for this year. As to cut the story short, it’s all about what a stock does that matters in eye of passive investors. In the case particular EPS growth for this year of stock, the chart notifies quite a story at present.
For passive investors (long-term) earning per shares and its growth is most valuable indicator for investment, as BPMX has EPS growth of 41.90% for this year, while SONS EPS growth standing at 56.20%for this year. Stocks with higher EPS growth rates are generally more preferred by investors than those with slower earnings-per-share growth rates, though in general high growth rates have a propensity to revert over the longer term to more even growth rates.
EPS calculates as net profit divided by No. of outstanding shares. The earnings per share (EPS) term represents portion of a company’s earnings with net of taxes as well as preferred stock dividends that is owed to each share of common stock. To ponder your chances of picking a winning stock, take a deep look at its fundamentals, particularly its EPS growth. Stocks with EPS growth rates of as a minimum 25% compared with year-ago levels suggest a company has products or services in strong demand.
BioPharmX Corporation (NYSE:BPMX) belongs to Healthcare sector, recorded a price change of 7.19% in last trade close. BPMX has the outstanding shares of 62.24. The company is estimating to achieve earnings per share (EPS) growth of 41.90% in this year. The indicator show clear picture of consistent history of earnings. Sometimes, companies with strong fundamentals but with low annualized EPS of less than 4 or 5 % but analysts may talk about a huge turnaround in the earnings due to heavy order book.
Its latest closing price kept its distance from the SMA50 at 11.20% and 11.11% compared with the SMA 20 while it was down/up 31.23% from the average-price of 200 days. The return on assets ratio of the Company was -497.00%. Price to sales ratio was 411.28 while 38.90% of stock was owned by Institutional investors.
Sonus Networks, Inc. (NASDAQ:SONS) ascend 1.41% to close at $7.90 in the last trading session. Its traded volume of 1.97 Million shares made it active as comparison to average volume of 506.60. A firm having high P/E ratio generally signified positive future performance and investors are willing to pay more for this company’s shares.
SONS offered -4.30% EPS for prior five years and the earnings per share (EPS) growth projected to be 56.20% in the coming year. Volatility of the stock was 4.20% for the week while for the month booked as 4.42%.